Ultrastructural study of skin biopsies in two cases of Gaucher disease (GD) patients (types II and III) revealed hitherto unknown alteration of the blood capillary endothelial cells (ECs) featured by hypertrophy and numerous subplasmalemmal microvesicles underneath both the apical and basal membranes. There was also prominent apical membrane folding with formation of filiform and large cytoplasmic projections, with occasional transcapillary cytoplasmic bridges. Similar, though less frequently expressed, changes were manifested at the basal membrane by numerous cytoplasmic projections into the subendothelial space. Regressive changes with EC breakdown were rare. Lysosomal storage was always absent. Besides EC hypertrophy, there was also increased EC density in the capillary lumen, leading to pronounced changes in capillary architecture with loose or incomplete EC anchoring. There were also signs of EC sprouting. Some pericytes displayed an increase in size and number of cytoplasmic processes, which often extended into distant pericapillary regions. The spectrum of changes suggests that a significant positive growth effect on EC occurs in GD. The putative mechanisms triggered by GBA1 deficiency leading to EC involvement are discussed. The authors are well aware of the fact the results, based on a nontraditional type of bioptic samples, are preliminary, but they are worth following, as further ultrastructural and functional studies of blood endothelium in GD may open a novel field in molecular cell pathophysiology of the disorder: endothelial dysfunction.

Faculty of Medicine and General Teaching Hospital Institute of Inherited Metabolic Disorders Charles University Prague Praha Czech Republic

See more in PubMed

Adar T, Ben-Ami R, Elstein D, et al. Increased red blood cell aggregation in patients with Gaucher disease is non-inflammatory. Clin Hemorheol Microcirc. 2008;40:113–118. PubMed

Aerts JM, Hollak CE. Plasma and metabolic abnormalities in Gaucher's disease. Baillieres Clin Haematol. 1997;10:691–709. doi: 10.1016/S0950-3536(97)80034-0. PubMed DOI

Agha-Majzoub R, Becker RP, Schraufnagel DE, et al. Angiogenesis: the major abnormality of the keratin-14 IL-4 transgenic mouse model of atopic dermatitis. Microcirculation. 2005;12:455–476. doi: 10.1080/10739680591003297. PubMed DOI

Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005;97:512–523. doi: 10.1161/01.RES.0000182903.16652.d7. PubMed DOI

Beutler E, Grabowski GA. Gaucher Disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. pp. 3635–3668.

Boot RG, Verhoek M, Donker-Koopman W, et al. Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2. J Biol Chem. 2007;282:1305–1312. doi: 10.1074/jbc.M610544200. PubMed DOI

Boven LA, van Meurs M, Boot RG, et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol. 2004;122:359–369. doi: 10.1309/BG5VA8JRDQH1M7HN. PubMed DOI

Burri PH, Djonov V. Intussusceptive angiogenesis–the alternative to capillary sprouting. Mol Aspects Med. 2002;23:S1–27. doi: 10.1016/S0098-2997(02)00096-1. PubMed DOI

Carpenter S. Morphological diagnosis and misdiagnosis in Batten-Kufs disease. Am J Med Genet Suppl. 1988;5:85–91. doi: 10.1002/ajmg.1320310611. PubMed DOI

Chen M, Wang J. Gaucher disease: review of the literature. Arch Pathol Lab Med. 2008;132:851–853. PubMed

Cogolludo A, Moreno L, Frazziano G, et al. Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovasc Res. 2009;82:296–302. doi: 10.1093/cvr/cvn349. PubMed DOI PMC

Cox TM. Biomarkers in lysosomal storage diseases: a review. Acta Paediatr Suppl. 2005;94:39–42. doi: 10.1080/08035320510028085. PubMed DOI

Deegan PB, Moran MT, McFarlane I, et al. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells Mol Dis. 2005;35:259–267. doi: 10.1016/j.bcmd.2005.05.005. PubMed DOI

Desnick RJ, Gatt S, Grabowski GA. Gaucher disease: a century of delineation and research. New York: Alan R. Liss; 1982.

Djonov V, Baum O, Burri PH. Vascular remodeling by intussusceptive angiogenesis. Cell Tissue Res. 2003;314:107–117. doi: 10.1007/s00441-003-0784-3. PubMed DOI

Dye J, Lawrence L, Linge C, et al. Distinct patterns of microvascular endothelial cell morphology are determined by extracellular matrix composition. Endothelium. 2004;11:151–167. doi: 10.1080/10623320490512093. PubMed DOI

Eblan MJ, Goker-Alpan O, Sidransky E. Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum. Fetal Pediatr Pathol. 2005;24:205–222. doi: 10.1080/15227950500405296. PubMed DOI

Eitzman DT, Bodary PF, Shen Y, et al. Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis. J Am Soc Nephrol. 2003;14:298–302. doi: 10.1097/01.ASN.0000043901.45141.D4. PubMed DOI

Elleder M. Sequelae of storage in Fabry disease--pathology and comparison with other lysosomal storage diseases. Acta Paediatr Suppl. 2003;92:46–53. doi: 10.1080/08035320310000465. PubMed DOI

Elleder M. Glucosylceramide transfer from lysosomes–the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data. J Inherit Metab Dis. 2006;29:707–715. doi: 10.1007/s10545-006-0411-z. PubMed DOI

Elstein D, Renbaum P, Levy-Lahad E, et al. Incidence of thrombophilia in patients with Gaucher disease. Am J Med Genet. 2000;95:429–431. doi: 10.1002/1096-8628(20001218)95:5<429::AID-AJMG4>3.0.CO;2-6. PubMed DOI

Elstein D, Nir A, Klutstein M, et al. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease. Blood Cells Mol Dis. 2005;34:201–205. doi: 10.1016/j.bcmd.2005.01.002. PubMed DOI

Fujimoto A, Onodera H, Mori A, et al. Vascular endothelial growth factor reduces mural cell coverage of endothelial cells and induces sprouting rather than luminal division in an HT1080 tumour angiogenesis model. Int J Exp Pathol. 2004;85:355–364. doi: 10.1111/j.0959-9673.2004.00404.x. PubMed DOI PMC

Gelderman MP, Schiffmann R, Simak J. Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapy. Arterioscler Thromb Vasc Biol. 2007;27:e138–139. doi: 10.1161/ATVBAHA.107.143511. PubMed DOI

Ghauharali-van der Vlugt K, Langeveld M, Poppema A, et al. Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. Clin Chim Acta. 2008;389:109–113. doi: 10.1016/j.cca.2007.12.001. PubMed DOI

Goldblatt J, Beighton P. Cutaneous manifestations of Gaucher disease. Br J Dermatol. 1984;111:331–334. doi: 10.1111/j.1365-2133.1984.tb04731.x. PubMed DOI

Groener JE, Poorthuis BJ, Kuiper S, et al. Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention. Biochim Biophys Acta. 2008;1781:72–78. PubMed

Hartree EF. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem. 1972;48:422–427. doi: 10.1016/0003-2697(72)90094-2. PubMed DOI

Hein LK, Duplock S, Hopwood JJ, et al. Lipid composition of microdomains is altered in a cell model of Gaucher disease. J Lipid Res. 2008;49:1725–1734. doi: 10.1194/jlr.M800092-JLR200. PubMed DOI PMC

Hodanova K, Hrebicek M, Cervenkova M, et al. Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles. Blood Cells Mol Dis. 1999;25:287–298. doi: 10.1006/bcmd.1999.0256. PubMed DOI

Hollak CE, Evers L, Aerts JM, et al. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Mol Dis. 1997;23:201–212. doi: 10.1006/bcmd.1997.0137. PubMed DOI

Hollak CE, Levi M, Berends F, et al. Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol. 1997;96:470–476. doi: 10.1046/j.1365-2141.1997.d01-2076.x. PubMed DOI

Holleran WM, Ginns EI, Menon GK, et al. Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest. 1994;93:1756–1764. doi: 10.1172/JCI117160. PubMed DOI PMC

Holleran WM, Takagi Y, Menon GK, et al. Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res. 1994;35:905–912. PubMed

Holleran WM, Ziegler SG, Goker-Alpan O, et al. Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease. Clin Genet. 2006;69:355–357. doi: 10.1111/j.1399-0004.2006.00589.x. PubMed DOI

Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol. 2003;23:1185–1189. doi: 10.1161/01.ATV.0000073832.49290.B5. PubMed DOI

Lee RE. The Pathology of Gaucher Disease. In: Desnick RJ, Gatt S, Grabowski GA, editors. Gaucher disease: a century of delineation and research. New York: Alan R. Liss; 1982. pp. 177–218.

Lee RE. Pathologic anatomy of Gaucher eisease: a pictorial essay. In: Futerman AH, Zimran A, editors. Gaucher disease. Boca Raton: CRC Press; 2007. pp. 197–223.

Liptak P, Kemeny E, Morvay Z, et al. Peritubular capillary damage in acute humoral rejection: an ultrastructural study on human renal allografts. Am J Transplant. 2005;5:2870–2876. doi: 10.1111/j.1600-6143.2005.01102.x. PubMed DOI

Lynch SF, Ludlam CA. Plasma microparticles and vascular disorders. Br J Haematol. 2007;137:36–48. PubMed

Martin S, Pitcher D, Tschen J, et al. Reactive angioendotheliomatosis. J Am Acad Dermatol. 1980;2:117–123. PubMed

Mignot C, Gelot A, Bessieres B, et al. Perinatal-lethal Gaucher disease. Am J Med Genet A. 2003;120A:338–344. doi: 10.1002/ajmg.a.20117. PubMed DOI

Michelakakis H, Spanou C, Kondyli A, et al. Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease. Biochim Biophys Acta. 1996;1317:219–222. PubMed

Norrby K. Angiogenesis: new aspects relating to its initiation and control. Apmis. 1997;105:417–437. doi: 10.1111/j.1699-0463.1997.tb00590.x. PubMed DOI

Park JL, Whitesall SE, D'Alecy LG, et al. Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect. Clin Exp Pharmacol Physiol. 2008;35:1156–1163. doi: 10.1111/j.1440-1681.2008.04984.x. PubMed DOI PMC

Pavelka M, Roth J. Functional ultrastructure. An atlas of tissue biology and pathology. Wien: Springer Verlag; 2005.

Planes C, Valeyre D, Loiseau A, et al. Ultrastructural alterations of the air-blood barrier in sarcoidosis and hypersensitivity pneumonitis and their relation to lung histopathology. Am J Respir Crit Care Med. 1994;150:1067–1074. PubMed

Polosukhin VV. Dynamics of the ultrastructural changes in blood and lymphatic capillaries of bronchi in inflammation and following endobronchial laser therapy. Virchows Arch. 1997;431:283–290. doi: 10.1007/s004280050100. PubMed DOI

Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med. 1995;6:230–247. doi: 10.1177/10454411950060030501. PubMed DOI

Reissner K, Tayebi N, Stubblefield BK, et al. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus. Mol Genet Metab. 1998;63:281–288. doi: 10.1006/mgme.1998.2675. PubMed DOI

Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674. doi: 10.1038/386671a0. PubMed DOI

Sharma R, Hudak ML, Perszyk AA, et al. Perinatal lethal form of Gaucher's disease presenting with hemosiderosis. Am J Perinatol. 2000;17:201–206. doi: 10.1055/s-2000-9419. PubMed DOI

Sherer DM, Metlay LA, Sinkin RA, et al. Congenital ichthyosis with restrictive dermopathy and Gaucher disease: a new syndrome with associated prenatal diagnostic and pathology findings. Obstet Gynecol. 1993;81:842–844. PubMed

Shyong EQ, Gorevic P, Lebwohl M, et al. Reactive angioendotheliomatosis and sarcoidosis. Int J Dermatol. 2002;41:894–897. doi: 10.1046/j.1365-4362.2002.01492_1.x. PubMed DOI

Sidransky E, Sherer DM, Ginns EI. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res. 1992;32:494–498. doi: 10.1203/00006450-199210000-00023. PubMed DOI

Spear GS, Beutler E, Hungs M. Congenital Gaucher disease with nonimmune hydrops/erythroblastosis, infantile arterial calcification, and neonatal hepatitis/fibrosis. Clinicopathologic report with enzymatic and genetic analysis. Fetal Pediatr Pathol. 2007;26:153–168. doi: 10.1080/15513810701563751. PubMed DOI

Stone DL, van Diggelen OP, de Klerk JB, et al. Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease? Eur J Hum Genet. 1999;7:505–509. doi: 10.1038/sj.ejhg.5200315. PubMed DOI

Takemura T, Shishiba T, Akiyama O, et al. Vascular involvement in cutaneous sarcoidosis. Pathol Int. 1997;47:84–89. doi: 10.1111/j.1440-1827.1997.tb03725.x. PubMed DOI

Tsukada N, Yanagisawa N, Mochizuki I. Endothelial cell damage in sarcoidosis and neurosarcoidosis: autoantibodies to endothelial cells. Eur Neurol. 1995;35:108–112. doi: 10.1159/000117103. PubMed DOI

Van Gysel D, Lijnen RL, Moekti SS, et al. Collodion baby: a follow-up study of 17 cases. J Eur Acad Dermatol Venereol. 2002;16:472–475. doi: 10.1046/j.1468-3083.2002.00477.x. PubMed DOI

van Weely S, Brandsma M, Strijland A, et al. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease. Biochim Biophys Acta. 1993;1181:55–62. PubMed

Vedder AC et al. (2009) Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment. Nephrol Dial Transplant 24(10):3074–3081 PubMed

Vissers JP, Langridge JI, Aerts JM. Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics. 2007;6:755–766. doi: 10.1074/mcp.M600303-MCP200. PubMed DOI

Vracko R, Benditt EP. Manifestations of diabetes mellitus–their possible relationships to an underlying cell defect. A review. Am J Pathol. 1974;75:204–224. PubMed PMC

Walski M, Frontczak-Baniewicz M. New vessel formation after surgical brain injury in the rat's cerebral cortex II. Formation of the blood vessels distal to the surgical injury. Acta Neurobiol Exp (Wars) 2003;63:77–82. PubMed

Wenger D, Williams C. Screening for Lysosomal Disorders. In: Hommes F, editor. Techniques in diagnostic human biochemical genetics. New York: Willey-Liss; 1991. pp. 587–617.

Xu Q. Progenitor cells in vascular repair. Curr Opin Lipidol. 2007;18:534–539. doi: 10.1097/MOL.0b013e3282a66082. PubMed DOI

Yildiz Y, Matern H, Thompson B, et al. Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility. J Clin Invest. 2006;116:2985–2994. doi: 10.1172/JCI29224. PubMed DOI PMC

Zhou AL, Egginton S, Brown MD, et al. Capillary growth in overloaded, hypertrophic adult rat skeletal muscle: an ultrastructural study. Anat Rec. 1998;252:49–63. doi: 10.1002/(SICI)1097-0185(199809)252:1<49::AID-AR6>3.0.CO;2-9. PubMed DOI